Affinia Therapeutics, an innovative gene therapy company with a pipeline of rationally designed adeno-associated virus (AAV) gene therapies for devastating cardiovascular and neurological diseases,...
GenEdit, Inc., a developer of genetic medicines that leverage its NanoGalaxy platform for tissue-selective delivery, announced the appointment of J. Rodrigo Mora, M.D., Ph.D.,...
Kindeva Drug Delivery, a global CDMO and drug delivery expert, has appointed Prakash Pandian as Chief Information Officer (CIO) to bolster its executive leadership team and...
Cellares, the world’s first Integrated Development and Manufacturing Organization (IDMO), and a leader in automated cell therapy manufacturing, has appointed Ossama Eissa, former executive...
Nutcracker Therapeutics, Inc., a pioneering biotechnology company dedicated to enabling transformative RNA therapies through its proprietary technology platform, announced its new contract research, development,...
